{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:03:38Z","timestamp":1789693418167,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-6-50"],"award-info":[{"award-number":["320.6750.2024-6-50"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1515230004"],"award-info":[{"award-number":["2023B1515230004"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112800","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:09:50Z","timestamp":1786201790000},"page":"112800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CaMKII\u03b3 inhibition attenuates osteoclastogenesis via the NF-\u03baB\u2013NFATc1 axis and protects against ovariectomy-induced osteoporosis"],"prefix":"10.1016","volume":"148","author":[{"given":"Yisen","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningnan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganghong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cellsig.2026.112800_bb0005","article-title":"Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"2","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"10514","key":"10.1016\/j.cellsig.2026.112800_bb0010","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0140-6736(25)01385-6","article-title":"Osteoporosis","volume":"406","author":"Ye","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2026.112800_bb0015","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112800_bb0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M22-1034","article-title":"Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians","volume":"176","author":"Qaseem","year":"2023","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112800_bb0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112800_bb0030","doi-asserted-by":"crossref","first-page":"e2141","DOI":"10.1210\/clinem\/dgae023","article-title":"Bisphosphonate use and risk of atypical femoral fractures: a Danish case-cohort study with blinded radiographic review","volume":"109","author":"Bauer","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/clinem\/dgaa756","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","volume":"106","author":"Tsourdi","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112800_bb0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","article-title":"Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases","volume":"56","author":"Takegahara","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-025-00853-6","article-title":"Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases","volume":"12","author":"Zhu","year":"2026","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2009.00821.x","article-title":"Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation","volume":"231","author":"Negishi-Koga","year":"2009","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112800_bb0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1749-6632.2009.05242.x","article-title":"Calmodulin-an often-ignored signal in osteoclasts","volume":"1192","author":"Williams","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112800_bb0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jcp.21076","article-title":"Calcium\/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL)","volume":"212","author":"Ang","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112800_bb0070","first-page":"2294","article-title":"Effects of Ca2+\/calmodulin-dependent protein kinase pathway inhibitor KN93 on osteoclastogenesis","volume":"42","author":"Fu","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112800_bb0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00223-018-0499-9","article-title":"Hyperglycemia induces osteoclastogenesis and bone destruction through the activation of ca(2+)\/calmodulin-dependent protein kinase II","volume":"104","author":"Shen","year":"2019","journal-title":"Calcif. Tissue Int."},{"issue":"Pt 2","key":"10.1016\/j.cellsig.2026.112800_bb0080","article-title":"CAMK2G in subcellular ca(2+) homeostasis: molecular mechanisms and therapeutic targeting","volume":"242","author":"Cao","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112800_bb0085","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/1535-7163.MCT-13-0314","article-title":"Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting ca(2)(+)\/calmodulin-dependent protein kinase II","volume":"12","author":"Meng","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccell.2017.06.001","article-title":"Stabilization of the c-Myc protein by CAMKIIgamma promotes T cell lymphoma","volume":"32","author":"Gu","year":"2017","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.cellsig.2026.112800_bb0095","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1182\/blood-2012-06-434894","article-title":"CaMKII gamma, a critical regulator of CML stem\/progenitor cells, is a target of the natural product berbamine","volume":"120","author":"Gu","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112800_bb0100","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1139\/o2012-002","article-title":"Differential protein and mRNA expression of CaMKs during osteoclastogenesis and its functional implications","volume":"90","author":"Yao","year":"2012","journal-title":"Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112800_bb0105","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s41418-024-01368-5","article-title":"Inhibition of inflammatory osteoclasts accelerates callus remodeling in osteoporotic fractures by enhancing CGRP(+)TrkA(+) signaling","volume":"31","author":"Shu","year":"2024","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112800_bb0110","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s12276-023-01085-y","article-title":"CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1\/HSP90beta complex","volume":"55","author":"Chen","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cellsig.2026.112800_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.751845","article-title":"Nox4 promotes RANKL-induced autophagy and osteoclastogenesis via activating ROS\/PERK\/eIF-2alpha\/ATF4 pathway","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112800_bb0120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbamcr.2010.11.002","article-title":"Calcium signaling in osteoclasts","volume":"1813","author":"Hwang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2026.112800_bb0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pathmechdis-031521-040919","article-title":"Osteoclasts, master sculptors of bone","volume":"18","author":"Veis","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cellsig.2026.112800_bb0130","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1111\/j.1749-6632.2011.06373.x","article-title":"New regulation mechanisms of osteoclast differentiation","volume":"1240","author":"Nakashima","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112800_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/cells12030401","article-title":"Calcium\/calmodulin-stimulated protein kinase II (CaMKII): different functional outcomes from activation, depending on the cellular microenvironment","volume":"12","author":"Rostas","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112800_bb0140","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm1515","article-title":"Regulation of osteoclast differentiation and function by the CaMK-CREB pathway","volume":"12","author":"Sato","year":"2006","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112800_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2024.10.012","article-title":"Convergence on CaMK4: a key modulator of autism-associated signaling pathways in neurons","volume":"97","author":"Kaiser","year":"2025","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cellsig.2026.112800_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110791","article-title":"CaMKII(delta) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway","volume":"508","author":"Lu","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41232-022-00213-x","article-title":"Osteoclast biology in the single-cell era","volume":"42","author":"Tsukasaki","year":"2022","journal-title":"Inflamm. Regen."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112800_bb0160","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1074\/mcp.M113.034371","article-title":"Characterization of functional reprogramming during osteoclast development using quantitative proteomics and mRNA profiling","volume":"13","author":"An","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112800_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20110062","article-title":"RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation","volume":"436","author":"Kim","year":"2011","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112800_bb0170","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4049\/jimmunol.0804165","article-title":"IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression","volume":"183","author":"Park-Min","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112800_bb0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4142\/jvs.2015.16.2.151","article-title":"Involvement of the ca(2)(+) signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation","volume":"16","author":"Fu","year":"2015","journal-title":"J. Vet. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112800_bb0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3803\/EnM.2023.501","article-title":"Nuclear factor-kappa B regulation of osteoclastogenesis and osteoblastogenesis","volume":"38","author":"Boyce","year":"2023","journal-title":"Endocrinol. Metab. (Seoul)"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112800_bb0185","doi-asserted-by":"crossref","first-page":"16175","DOI":"10.3390\/ijms242216175","article-title":"Role and regulation of transcription factors in osteoclastogenesis","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112800_bb0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/MCB.00912-13","article-title":"Role of Ca2+\/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-kappaB activation","volume":"34","author":"Kim","year":"2014","journal-title":"Mol. Cell. Biol."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112800_bb0195","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1128\/MCB.02469-05","article-title":"Ca2+\/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation","volume":"26","author":"Ishiguro","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112800_bb0200","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/ijlh.13440","article-title":"CaMKIIgamma regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5\/NF-kappaB pathway","volume":"43","author":"Cheng","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3803\/EnM.2015.30.1.35","article-title":"NF-kappaB-mediated regulation of osteoclastogenesis","volume":"30","author":"Boyce","year":"2015","journal-title":"Endocrinol. Metab. (Seoul)"},{"issue":"14","key":"10.1016\/j.cellsig.2026.112800_bb0210","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.3390\/ijms23147995","article-title":"Critical roles of NF-kappaB signaling molecules in bone metabolism revealed by genetic mutations in osteopetrosis","volume":"23","author":"Jimi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112800_bb0215","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112800_bb0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","article-title":"Regulation of NFATc1 in osteoclast differentiation","volume":"21","author":"Kim","year":"2014","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.cellsig.2026.112800_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115589","article-title":"Sofalcone inhibits osteoclastogenesis through Keap1\/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss","volume":"166","author":"Liang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112800_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157472","article-title":"Bisabolangelone targets CSF1R to impede osteoclastogenesis and attenuate estrogen-deficiency bone loss","volume":"148","author":"Mo","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cellsig.2026.112800_bb0235","doi-asserted-by":"crossref","first-page":"1032866","DOI":"10.3389\/fphar.2022.1032866","article-title":"Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss","volume":"13","author":"Qi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112800_bb0240","article-title":"The dibenzyl isoquinoline alkaloid berbamine ameliorates osteoporosis by inhibiting bone resorption","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112800_bb0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112800_bb0250","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41589-021-00865-9","article-title":"Discovering new biology with drug-resistance alleles","volume":"17","author":"Freedy","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cellsig.2026.112800_bb0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbrc.2021.06.025","article-title":"Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIgamma inhibitor, against glioblastoma","volume":"566","author":"Kim","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112800_bb0260","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/bloodadvances.2020003303","article-title":"CAMK2G is identified as a novel therapeutic target for myelofibrosis","volume":"6","author":"Miyauchi","year":"2022","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112800_bb0265","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jcm10010152","article-title":"Denosumab discontinuation and the rebound phenomenon: a narrative review","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112800_bb0270","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/jbmr\/zjae159","article-title":"Atypical fractures at non-classical sites associated with anti-resorptive therapy: a systematic review","volume":"39","author":"Collins","year":"2024","journal-title":"J. Bone Miner. Res."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112800_bb0275","doi-asserted-by":"crossref","first-page":"13668","DOI":"10.18632\/aging.103490","article-title":"CAMKIIgamma is a targetable driver of multiple myeloma through CaMKIIgamma\/ Stat3 axis","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cellsig.2026.112800_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109134","article-title":"Novel synthetic tosyl chloride-berbamine regresses lethal MYC-positive leukemia by targeting CaMKIIgamma\/Myc axis","volume":"117","author":"Yu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112800_bb0285","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hon.3010","article-title":"Targeting MYC and BCL2 by a natural compound for \u201cdouble-hit\u201d lymphoma","volume":"40","author":"Liu","year":"2022","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112800_bb0290","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jchromb.2013.04.007","article-title":"A rapid and sensitive LC-MS\/MS assay for the determination of berbamine in rat plasma with application to preclinical pharmacokinetic study","volume":"929","author":"Liu","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cellsig.2026.112800_bb0295","doi-asserted-by":"crossref","first-page":"1509860","DOI":"10.3389\/fphar.2025.1509860","article-title":"Berbamine attenuates hind limb ischemia-reperfusion injury by eliminating lipid ROS and inhibiting p65 nuclear translocation","volume":"16","author":"Zheng","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112800_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116719","article-title":"Perspective: the current state of Cre driver mouse lines in skeletal research: challenges and opportunities","volume":"170","author":"Cunningham","year":"2023","journal-title":"Bone"},{"issue":"19","key":"10.1016\/j.cellsig.2026.112800_bb0305","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.7150\/thno.99565","article-title":"Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolism","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:15:34Z","timestamp":1789690534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":61,"alternative-id":["S0898656826004584"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112800","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CaMKII\u03b3 inhibition attenuates osteoclastogenesis via the NF-\u03baB\u2013NFATc1 axis and protects against ovariectomy-induced osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112800"}}